Yellow Fever Vaccine Safety and Immune Response in Pregnancy
Treatments studied
Part of Infections clinical trials.
This study gathers safety and antibody information from women who received their first yellow fever vaccine either during pregnancy or outside of pregnancy. It aims to better understand how the vaccine affects pregnant women and their babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You received your first yellow fever vaccine either during pregnancy or while not pregnant
- You were not born in a region where yellow fever is common (like parts of Africa or South America)
- You have had only one yellow fever vaccine dose in your lifetime (no second dose)
- For the immunogenicity part: you must be able to give written consent and have about 18.5 mL (1.2 tablespoons) of blood drawn
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system “remembers” the yellow fever vaccine over time. It may help researchers understand long-term immune protection and how it varies between people.
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
This trial tests a new yellow fever vaccine in young children. It will see if the vaccine is safe and produces a good immune response, including when given with the MMR vaccine.
This trial studies how well the yellow fever vaccine “17D” stimulates the immune system (the body’s germ-fighting response) in adults who were vaccinated with 17D years ago. It may help researchers understand whether a prior vaccination still provides protection and how strong the immune response is.
This trial checks whether a yellow fever vaccine is safe and works well in adults with HIV who have relatively healthy immune function. It may help doctors understand the best way to protect people with HIV who have never had this vaccine.
This trial checks whether giving the measles-rubella (MR) and yellow fever vaccines at the same time is safe and works well in healthy babies aged 9 to 12 months. It may help simplify the vaccination schedule.
Hear when a new Yellow Fever Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.